PFG Investments LLC acquired a new position in McKesson Co. (NYSE:MCK – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 427 shares of the company’s stock, valued at approximately $249,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Avantax Advisory Services Inc. boosted its position in McKesson by 20.0% during the 4th quarter. Avantax Advisory Services Inc. now owns 1,847 shares of the company’s stock valued at $855,000 after acquiring an additional 308 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of McKesson by 0.3% during the 4th quarter. Janney Montgomery Scott LLC now owns 33,163 shares of the company’s stock valued at $15,354,000 after purchasing an additional 91 shares during the last quarter. Fiera Capital Corp purchased a new stake in shares of McKesson during the 4th quarter valued at $713,000. Navellier & Associates Inc. purchased a new stake in shares of McKesson during the 4th quarter valued at $201,000. Finally, Private Wealth Management Group LLC purchased a new stake in shares of McKesson during the 4th quarter valued at $60,000. Institutional investors own 85.07% of the company’s stock.
Analyst Ratings Changes
A number of brokerages recently issued reports on MCK. Bank of America raised their target price on McKesson from $590.00 to $670.00 and gave the stock a “buy” rating in a research note on Tuesday, June 25th. Citigroup reduced their target price on McKesson from $670.00 to $630.00 and set a “buy” rating for the company in a research note on Tuesday. Barclays increased their price target on McKesson from $596.00 to $616.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. Mizuho increased their price target on McKesson from $540.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, August 8th. Finally, Robert W. Baird cut their price target on McKesson from $694.00 to $671.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, McKesson has a consensus rating of “Moderate Buy” and a consensus price target of $620.93.
McKesson Trading Up 1.5 %
MCK stock opened at $518.81 on Friday. McKesson Co. has a 12-month low of $417.65 and a 12-month high of $637.51. The stock has a market cap of $67.28 billion, a price-to-earnings ratio of 23.18, a PEG ratio of 1.18 and a beta of 0.44. The business’s 50-day moving average is $567.33 and its 200 day moving average is $557.25.
McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.21 by $0.67. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The company had revenue of $79.28 billion for the quarter, compared to analysts’ expectations of $82.53 billion. During the same period in the previous year, the firm posted $7.27 EPS. McKesson’s revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts forecast that McKesson Co. will post 32.11 EPS for the current fiscal year.
McKesson Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.55%. This is a positive change from McKesson’s previous quarterly dividend of $0.62. The ex-dividend date is Friday, August 30th. McKesson’s dividend payout ratio (DPR) is 12.69%.
Insiders Place Their Bets
In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $626.03, for a total value of $2,349,490.59. Following the transaction, the chief executive officer now directly owns 82,339 shares of the company’s stock, valued at approximately $51,546,684.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 11,259 shares of company stock valued at $6,635,492 in the last ninety days. 0.11% of the stock is currently owned by corporate insiders.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- How to Invest in Biotech Stocks
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- What is the S&P 500 and How It is Distinct from Other Indexes
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.